SCHEMBL5019057

SCHEMBL5019057

CC(C)(C)OC(=O)NCCC(O)CCNC(=O)OC(C)(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.61
GAA P10253 1/20 0.61
KMT2A Q03164 1/20 0.61
TDP1 Q9NUW8 1/20 0.55
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
CA1 P00915 5/20 0.45
CA2 P00918 5/20 0.45
CA12 O43570 4/20 0.45
CA9 Q16790 4/20 0.45
EPHX1 P07099 1/20 0.45
MALT1 Q9UDY8 1/20 0.42
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CA7 P43166 1/20 0.41
ALDH1A1 P00352 1/20 0.40
GFER P55789 1/20 0.40
KCNA5 P22460 1/20 0.40
CYP2D6 P10635 1/20 0.40
CTSS P25774 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22433494 0.94 MEN1 (0.56) MEN1GAAKMT2ATDP1MAOA
SCHEMBL16622956 0.93 MEN1 (0.54) MEN1GAAKMT2ATDP1MAOA
SCHEMBL16917206 0.93 MEN1 (0.54) MEN1GAAKMT2ATDP1MAOA
SCHEMBL28229416 0.91 MEN1 (0.53) MEN1GAAKMT2ATDP1MAOA
SCHEMBL10331455 0.91 MEN1 (0.53) MEN1GAAKMT2ATDP1MAOA
SCHEMBL23690865 0.91 MEN1 (0.56) MEN1GAAKMT2ATDP1MAOA
SCHEMBL17452213 0.91 MEN1 (0.56) MEN1GAAKMT2ATDP1MAOA
SCHEMBL751969 0.91 MEN1 (0.56) MEN1GAAKMT2ATDP1MAOA
SCHEMBL8194926 0.91 MEN1 (0.56) MEN1GAAKMT2ATDP1MAOA
SCHEMBL21396771 0.90 MEN1 (0.55) MEN1GAAKMT2ATDP1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12358951-B2 Cyclic peptide antibiotics GENENTECH, INC. (US) 2025-07-15 US disclosed
US-20230025834-A1 CYCLIC PEPTIDE ANTIBIOTICS GENENTECH, INC. (US) 2023-01-26 US disclosed
US-20230025834-A1 CYCLIC PEPTIDE ANTIBIOTICS GENENTECH, INC. (US) 2023-01-26 US disclosed
CN-113710687-A Cyclopeptide antibiotics 豪夫迈·罗氏有限公司 2021-11-26 CN disclosed
WO-2020185999-A1 CYCLIC PEPTIDE ANTIBIOTICS GENENTECH, INC. (US) 2020-09-17 WO disclosed
US-8178490-B2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2012-05-15 US disclosed
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2010-06-17 US disclosed
WO-2010054102-A2 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025834-A1 CYCLIC PEPTIDE ANTIBIOTICS NPPA, LNPEP, CLPP MEN1 4359/4885GAA 844/4885KMT2A 1737/4885
US-12358951-B2 Cyclic peptide antibiotics NPPA, LNPEP, CLPP MEN1 4359/4885GAA 844/4885KMT2A 1737/4885
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF ABCB11, ABCB1, SLC47A1 MEN1 4473/4885GAA 67/4885KMT2A 3928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.